1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Lebanon Pharmaceuticals and Healthcare Report Q3 2016

Lebanon Pharmaceuticals and Healthcare Report Q3 2016

  • May 2016
  • -
  • Business Monitor International
  • -
  • 81 pages

Includes 3 FREE quarterly updates

BMI View: We believe the Lebanese government's focus on improving healthcare access and quality acrossthe country coupled with a rising disease burden and relatively high per capita spending will drive thedemand of high-value prescription medicines. The Ministry of Health's crackdown on poor health practiceshighlights the country's commitment to improving pharmaceutical and healthcare standards. However, theongoing Syrian refugee crisis, emergence of Islamic State violence and economic stagnation will continueto dampen multinational drugmakers' interest in the market.

Headline Expenditure Projections

- Pharmaceuticals: LBP2.47trn (USD1.64bn) in 2015 to LBP2.63trn (USD1.74bn) in 2016; +6.6% inlocal currency and US dollar terms. Forecast in line with last quarter.

- Healthcare: LBP5.04trn (USD3.34bn) in 2015 to LBP5.27trn (USD3.50bn) in 2016; +4.8% in localcurrency and US dollar terms. Forecast revised downwards from last quarter.

Table Of Contents

Lebanon Pharmaceuticals and Healthcare Report Q3 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Lebanon 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Lebanon 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Lebanon 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Lebanon 2012-2020) 17
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Lebanon 2012-2020) 18
Prescription Drug Market Forecast 19
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Lebanon 2012-2020) 20
Patented Drug Market Forecast 21
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Lebanon 2012-2020) 23
Generic Drug Market Forecast 24
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Lebanon 2012-2020) 26
OTC Medicine Market Forecast 27
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Lebanon 2012-2020) 28
Pharmaceutical Trade Forecast 29
Table: Pharmaceutical Trade Data And Forecasts (Lebanon 2014-2020) 32
Table: Pharmaceutical Trade Data And Forecasts local currency (Lebanon 2014-2020) 32
Industry Risk/Reward Index 33
Middle East and Africa Risk/Reward Index - Q3 2016 33
Lebanon Risk/Reward Index 41
Rewards 41
Risks 41
Regulatory Review 43
Regulatory Developments 43
Counterfeit Drugs 45
Public Sector Procurement 45
Intellectual Property Issues 46
Free Trade Agreements 47
Pricing Regime 48
Reimbursement Regime 50
Market Overview 51
Healthcare Sector 52
Medical Tourism 55
Regional Healthcare Collaboration 56
Clinical Trials 57
Epidemiology 58
Competitive Landscape 60
Research-Based Industry 60
Table: Multinational Market Activity 60
Generic Drugmakers 61
Pharmaceutical Distribution 63
Pharmacy Retail Sector 63
Company Profile 65
Algorithm 65
Pharmaline 67
Demographic Forecast 70
Table: Population Headline Indicators (Lebanon 1990-2025) 71
Table: Key Population Ratios (Lebanon 1990-2025) 71
Table: Urban/Rural Population and Life Expectancy (Lebanon 1990-2025) 72
Table: Population By Age Group (Lebanon 1990-2025) 72
Table: Population By Age Group % (Lebanon 1990-2025) 73
Glossary 75
Methodology 77
Pharmaceutical Expenditure Forecast Model 77
Healthcare Expenditure Forecast Model 77
Notes On Methodology 78
Risk/Reward Index Methodology 79
Index Overview 80
Table: Pharmaceutical Risk/Reward Index Indicators 80
Indicator Weightings 81

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Prostate Cancer Pricing, Reimbursement, and Access

Prostate Cancer Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

Novel antiandrogens will need to present risk-sharing agreements in EU markets, while discussing contracting with US payers to ensure a competitive advantage. Vaccines suffer from inconclusive response ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7 000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

IMS World Review Executive™ 2016

IMS World Review Executive™ 2016

  • $ 6 860
  • Industry report
  • July 2016
  • by IMS Health

IMS World Review ExecutiveTM 2016 provides essential insights into worldwide sales of the pharmaceutical market, interlocking market trends and sales analysis from 2011 to 2015, including the breakdown ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.